Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027352 · ClinicalTrials.gov registry record
A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 6,000
- Enrollment target
NCT00027352: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00027352 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 6,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00027352 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 6,000 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two ways of using anti-HIV drugs to help health care providers and patients decide how to best use anti-HIV treatments over many years. Many health care providers now treat patients with daily drugs to keep the viral load as low as possible. This approach helps patients with CD4 counts less than 200-250 cells/mm3 live longer without serious diseases. But it is not known if this is the best way to treat patients with higher CD4 counts. There is information suggesting that these patients may be able to wait to use anti-HIV drugs while CD4 counts are above 250 cells/mm3. Because this study will be carried out over several years, it will provide information on the long-term advantages and disadvantages of these two treatment strategies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
What the finished NCT00027352 record still lists
NCT00027352 is an observational study that tracks outcomes without assigning an intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00027352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00027352 about?
NCT00027352 is a clinical study titled "A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)". The purpose of this study is to compare two ways of using anti-HIV drugs to help health care providers and patients decide how to best use anti-HIV treatments over many years. Many health care providers now treat patients with daily drugs to keep the viral load as low as possible. This approach help...
What is the current status of trial NCT00027352?
This trial is currently completed. The enrollment target is 6,000 participants.
Who is sponsoring clinical trial NCT00027352?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site